DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Tzimopoulou S, Cunningham VJ, Nichols TE , et al.
A multi-center randomized proof-of-concept clinical trial applying [18F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
J Alzheimers Dis 2010;
22 (4) 1241-1256
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.